NASDAQ: MTEXMannatech Inc Stock
$8.33+0.13 (+1.59%)
Updated Apr 19, 2024
MTEX Price
$8.33
Fair Value Price
$13.13
Market Cap
$15.71M
52 Week Low
$7.50
52 Week High
$15.10
P/E
-6.94x
P/B
1.5x
P/S
0.12x
PEG
N/A
Dividend Yield
2.4%
Revenue
$131.96M
Earnings
-$2.24M
Gross Margin
78%
Operating Margin
-0.86%
Profit Margin
-1.7%
Debt to Equity
2.93
Operating Cash Flow
-$2M
Beta
0.41
Next Earnings
May 10, 2024
Ex-Dividend
N/A
Next Dividend
N/A
MTEX Overview
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MTEX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MTEX ($8.33) is undervalued by 36.51% relative to our estimate of its Fair Value price of $13.13 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MTEX ($8.33) is significantly undervalued by 36.51% relative to our estimate of its Fair Value price of $13.13 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MTEX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more MTEX due diligence checks available for Premium users.
Be the first to know about important MTEX news, forecast changes, insider trades & much more!
MTEX News
Valuation
MTEX fair value
Fair Value of MTEX stock based on Discounted Cash Flow (DCF)
Price
$8.33
Fair Value
$13.13
Undervalued by
36.54%
MTEX ($8.33) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MTEX ($8.33) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MTEX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MTEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-6.94x
Industry
34.65x
Market
40.51x
MTEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.5x
Industry
7.15x
MTEX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MTEX's financial health
Profit margin
Revenue
$32.7M
Net Income
-$1.8M
Profit Margin
-5.4%
MTEX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MTEX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$41.2M
Liabilities
$30.7M
Debt to equity
2.93
MTEX's short-term assets ($27.66M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTEX's short-term assets ($27.66M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MTEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.3M
Investing
-$208.0k
Financing
-$274.0k
MTEX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MTEX vs Household & Personal Product Stocks
Mannatech Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.